Enhanced Protein Expression of Signal Transducer and Activator of Transcription 3 and Protein Kinase Substrate p36 in Hepatocellular Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : Signal transducers and activators of transcription 3 (STAT3) and protein kinase substrate p36 may be involved in cell proliferation, differentiation and growth. Methods : Immunohistochemistry for STAT3 and p36 was performed in 46 patients with hepatocellular carcinoma (HCC). Results : STAT3 staining was present in the cytoplasm and/or nucleus, while p36 staining was present in the nucleus. STAT3 and p36 expression occurred in 78.3% (36/46) and 47.8% (22/46) of HCC patients, respectively. However, no correlation was found between STAT3 and p36 protein expression (p>0.05). Enhanced expression of STAT3 was negatively correlated with portal vein invasion (p=0.033). Expression of STAT3 in the nucleus was correlated with tumor grade (p=0.004). Enhanced expression of p36 was correlated with tumor grade (p=0.031). HCC was correlated with HBV infection (p=0.032). The patients’ 5- year survival was related to expression of p36 (p=0.044), but not to total STAT3 or nuclear STAT3 (p>0.05). Conclusions : The enhanced expression of STAT3 in the nucleus and the enhanced expression of p36 are associated with the aggressive phenotype of HCC. Enhanced p36 expression may contribute to poor survival of patients with HCC.
Abstract
Background : Signal transducers and activators of transcription 3 (STAT3) and protein kinase substrate p36 may be involved in cell proliferation, differentiation and growth. Methods : Immunohistochemistry for STAT3 and p36 was performed in 46 patients with hepatocellular carcinoma (HCC). Results : STAT3 staining was present in the cytoplasm and/or nucleus, while p36 staining was present in the nucleus. STAT3 and p36 expression occurred in 78.3% (36/46) and 47.8% (22/46) of HCC patients, respectively. However, no correlation was found between STAT3 and p36 protein expression (p>0.05). Enhanced expression of STAT3 was negatively correlated with portal vein invasion (p=0.033). Expression of STAT3 in the nucleus was correlated with tumor grade (p=0.004). Enhanced expression of p36 was correlated with tumor grade (p=0.031). HCC was correlated with HBV infection (p=0.032). The patients’ 5- year survival was related to expression of p36 (p=0.044), but not to total STAT3 or nuclear STAT3 (p>0.05). Conclusions : The enhanced expression of STAT3 in the nucleus and the enhanced expression of p36 are associated with the aggressive phenotype of HCC. Enhanced p36 expression may contribute to poor survival of patients with HCC.
참고문헌 (24)
- Parkin DM, "Global cancer statistics, 2002", CA Cancer J C, 55, pp.74~108 (2005)
- Bosch FX, "Epidemiology of primary liver cancer", Semin Liver Dis, 19, pp.271~285 (1999)
- Park JH, "Identification of the genes involved in enhanced fenretinide-induced apoptosis by parthenolide in human hepatoma cells", Cancer Res, 65, pp.2804~2814 (2005)
- Watanabe T, "Identification of immunoglobulin superfamily 11 (IGSF11) as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas", Cancer Sci, 96, pp.498~506 (2005)
- Bromberg J, "The role of STATs in transcriptional control and their impact on cellular function", Oncogene, 19, pp.2468~2473 (2000)
- Mui AL, "The role of STATs in proliferation, differentiation, and apoptosis", Cell Mol Life Sci, 55, pp.1547~1558 (1999)
- Coffer PJ, "The role of STATs in myeloid differentiation and leukemia", Oncogene, 19, pp.2511~2522 (2000)
- Song JI, "STAT signaling in head and neck cancer", Oncogene, 19, pp.2489~2495 (2000)
- Kannangai R, "EGFR is phosphorylated at Ty845 in hepatocellular carcinoma", Mod Pathol, 19, pp.1456~1461 (2006)
- Radke K, "Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific protein phosphorylation contains phosphotyrosine", Cell, 21, pp.821~828 (1980)
- Erikson E, "Evidence that viral transforming gene products and epidermal growth factor stimulate phosphorylation of the same cellular protein with similar specificity", J Biol Chem, 256, pp.11381~11384 (1981)
- Isacke CM, "Modulation of p36 phosphorylation in human cells: studies using anti-p36 monoclonal antibodies", Mol Cell Biol, 6, pp.2745~2751 (1986)
- Liang YC, "Involvement of fatty acid-CoA ligase 4 in hepatocellular carcinoma growth: roles of cyclic AMP and p38 mitogen-activated protein kinase", World J Gastroenterol, 11, pp.2557~2563 (2005)
- Biswas KK, "Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1", 2 and the downregulation of Akt, 2006, pp.580, 703~710
- Osada S, "Evalua-tion of extracellular signal regulated kinase expression and its relation to treatment of hepatocellular carcinoma", J Am Coll Surg, 201, pp.405~411 (2005)
- Frohlich M, "Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma", Mol Cell Biol, 10, pp.3216~3223 (1990)
- Schoppmann SF, "Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer", Int J Cancer, 104, pp.677~682 (2003)
- Gao B, "Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells", FEBS Lett, 488, pp.179~184 (2001)
- Garcia R, "Constitutive activation of STAT3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells", Oncogene, 20, pp.2499~2513 (2001)
- Silver DL, "Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility", Cancer Res, 64, pp.3550~3558 (2004)
- Sanchez A, "STAT-3 activity in chemically-induced hepatocellular carcinoma", Eur J Cancer, 39, pp.2093~2098 (2003)
- Burgoyne RD, "Calpactin in exocytosis", Nature, 331, pp.20~ (1988)
- Fukutomi T, "Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression", Hepatology, 41, pp.1096~1105 (2005)
- Lee TH, "Enhanced nuclear factor-kappa Bassociated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis:identification by functional proteomics", J Biomed Sci, 13, pp.27~39 (2006)